
Aridis Pharmaceuticals ARDS
Quarterly report 2023-Q3
added 11-06-2023
Aridis Pharmaceuticals Current Ratio 2011-2026 | ARDS
Annual Current Ratio Aridis Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.378 | 0.671 | 0.568 | 1.34 | 5.35 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.35 | 0.378 | 1.66 |
Quarterly Current Ratio Aridis Pharmaceuticals
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.36 | 0.38 | 0.25 | 0.37 | 0.54 | 0.67 | 0.86 | 0.46 | 0.67 | 0.64 | 0.64 | 0.64 | 0.64 | 1.15 | 1.15 | 1.15 | 1.15 | 5.97 | 5.97 | 5.97 | 5.97 | 1.76 | 1.76 | 1.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.97 | 0.25 | 1.7 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
1.12 | $ 2.11 | -13.17 % | $ 217 M | ||
|
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | ||
|
Apellis Pharmaceuticals
APLS
|
1.52 | $ 20.52 | -2.12 % | $ 2.59 B | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
Axsome Therapeutics
AXSM
|
1.15 | $ 164.13 | 0.15 % | $ 8.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
1.47 | $ 2.49 | -3.11 % | $ 15.6 M | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M | ||
|
BridgeBio Pharma
BBIO
|
0.311 | $ 64.24 | -3.37 % | $ 12.3 B | ||
|
BioAtla
BCAB
|
2.44 | $ 0.18 | -26.92 % | $ 8.6 M | ||
|
BioCardia
BCDA
|
0.651 | $ 1.37 | 6.2 % | $ 29 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
0.507 | $ 8.61 | -1.66 % | $ 1.78 B | ||
|
Black Diamond Therapeutics
BDTX
|
3.12 | $ 2.4 | -3.04 % | $ 132 M | ||
|
Beam Therapeutics
BEAM
|
6.1 | $ 28.29 | -0.6 % | $ 2.8 B | ||
|
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.612 | $ 11.47 | -0.43 % | $ 742 M | ||
|
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | ||
|
Biogen
BIIB
|
2.63 | $ 187.68 | -2.16 % | $ 27.5 B | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
BioVie
BIVI
|
8.46 | $ 1.38 | -0.01 % | $ 2.04 M | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
7.98 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | ||
|
BioLineRx Ltd.
BLRX
|
1.53 | $ 2.91 | 2.83 % | $ 908 M | ||
|
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | ||
|
BioMarin Pharmaceutical
BMRN
|
5.04 | $ 60.68 | -1.7 % | $ 11.6 B | ||
|
Bristol-Myers Squibb Company
BMY
|
1.26 | $ 62.54 | 0.27 % | $ 127 B | ||
|
Benitec Biopharma
BNTC
|
43.4 | $ 10.85 | -0.5 % | $ 447 M | ||
|
BioNTech SE
BNTX
|
7.22 | $ 109.85 | -0.34 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | ||
|
BioXcel Therapeutics
BTAI
|
0.292 | $ 1.63 | -2.69 % | $ 4.13 M | ||
|
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | ||
|
Burford Capital Limited
BUR
|
2.14 | $ 8.6 | 1.9 % | $ 1.39 B | ||
|
Athira Pharma
ATHA
|
4.22 | - | - | $ 269 M |